At 10:30 am on Tuesday, several stocks were identified as top gainers on the Nifty Midcap 150 index. These included KPR Mill, Global Health, MRF, Balkrishna Ind, and GE Vernova TD.
KPR Mill led the gains with a 3.63% increase, reaching a price of Rs 1,085.00. Global Health followed, rising by 3.49% to Rs 1,371.80. MRF also saw a significant gain, increasing by 3.14% to Rs 152,035.00.
Balkrishna Ind recorded a gain of 2.68%, trading at Rs 2,468.00, while GE Vernova TD saw an increase of 2.42%, reaching Rs 2,920.10.
KPR Mill Financial Performance
KPR Mill's consolidated financial performance shows consistent revenue and net profit over the recent quarters. The company has also demonstrated steady growth in annual revenue.
| Quarter | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS |
|---|---|---|---|
| Jun 2024 | 1,609.66 | 203.31 | 5.95 |
| Sep 2024 | 1,480.02 | 205.00 | 6.00 |
| Dec 2024 | 1,529.22 | 202.25 | 5.92 |
| Mar 2025 | 1,768.98 | 204.55 | 5.98 |
| Jun 2025 | 1,766.27 | 212.70 | 6.22 |
The revenue for the quarter-ending June 2025 stood at Rs 1,766.27 Crore, compared to Rs 1,609.66 Crore for the quarter-ending June 2024. Net profit for the same period was Rs 212.70 Crore, up from Rs 203.31 Crore.
| Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2021 | 3,530.15 | 515.26 | 74.88 | 341.50 | 21.92 | 0.26 |
| 2022 | 4,822.48 | 841.84 | 24.47 | 92.61 | 26.41 | 0.37 |
| 2023 | 6,185.88 | 814.10 | 23.81 | 108.45 | 21.96 | 0.36 |
| 2024 | 6,059.68 | 805.35 | 23.56 | 127.51 | 18.47 | 0.27 |
| 2025 | 6,387.88 | 815.11 | 23.85 | 146.34 | 16.29 | 0.09 |
The annual revenue for the year-ending March 2025 increased to Rs 6,387.88 Crore from Rs 6,059.68 Crore in the year-ending March 2024. The net profit also saw a slight increase, rising to Rs 815.11 Crore from Rs 805.35 Crore.
| Income Statement Yearly (Rs Crore) | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | 6,387 | 6,059 | 6,185 | 4,822 | 3,530 |
| Other Income | 74 | 67 | 62 | 87 | 38 |
| Total Income | 6,462 | 6,126 | 6,248 | 4,909 | 3,568 |
| Total Expenditure | 5,349 | 5,012 | 5,085 | 3,744 | 2,847 |
| EBIT | 1,112 | 1,114 | 1,163 | 1,164 | 721 |
| Interest | 49 | 74 | 78 | 23 | 32 |
| Tax | 247 | 235 | 270 | 299 | 173 |
| Net Profit | 815 | 805 | 814 | 841 | 515 |
Global Health's financial data indicates steady revenue growth, accompanied by fluctuating net profit and EPS figures.
| Quarter | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS |
|---|---|---|---|
| Jun 2024 | 861.08 | 106.26 | 3.96 |
| Sep 2024 | 956.56 | 130.82 | 4.87 |
| Dec 2024 | 943.44 | 142.86 | 5.32 |
| Mar 2025 | 931.25 | 101.38 | 3.77 |
| Jun 2025 | 1030.84 | 158.98 | 5.92 |
The revenue for the quarter-ending June 2025 was Rs 1,030.84 Crore, up from Rs 861.08 Crore in the quarter-ending June 2024. Net profit also increased to Rs 158.98 Crore from Rs 106.26 Crore.
| Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2022 | 2,166.59 | 196.20 | 7.78 | 63.82 | 12.14 | 0.52 |
| 2023 | 2,694.25 | 326.08 | 12.58 | 90.54 | 13.42 | 0.35 |
| 2024 | 3,275.11 | 478.06 | 17.80 | 108.21 | 16.45 | 0.14 |
| 2025 | 3,692.32 | 481.32 | 17.92 | 126.08 | 14.21 | 0.10 |
The yearly revenue increased to Rs 3,692.32 Crore for the year-ending March 2025, compared to Rs 3,275.11 Crore for the year-ending March 2024. Net profit also saw a slight increase to Rs 481.32 Crore from Rs 478.06 Crore.
| Income Statement Yearly (Rs Crore) | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Sales | 3,204 | 2,280 | 1,959 |
| Other Income | 90 | 102 | 61 |
| Total Income | 3,295 | 2,382 | 2,021 |
| Total Expenditure | 2,638 | 1,869 | 1,643 |
| EBIT | 656 | 513 | 377 |
| Interest | 33 | 24 | 26 |
| Tax | 161 | 127 | 88 |
| Net Profit | 461 | 360 | 263 |
MRF’s consolidated financial performance shows consistent revenue and net profit over the recent quarters. The company has also demonstrated steady growth in annual revenue.
| Quarter | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS |
|---|---|---|---|
| Jun 2024 | 7,196.45 | 571.02 | 1,346.38 |
| Sep 2024 | 6,881.09 | 470.70 | 1,109.85 |
| Dec 2024 | 7,000.82 | 315.46 | 743.80 |
| Mar 2025 | 7,074.82 | 512.11 | 1,207.48 |
| Jun 2025 | 7,675.69 | 500.47 | 1,180.04 |
The revenue for the quarter-ending June 2025 stood at Rs 7,675.69 Crore, compared to Rs 7,196.45 Crore for the quarter-ending June 2024. Net profit for the same period was Rs 500.47 Crore, down from Rs 571.02 Crore.
| Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2021 | 16,163.19 | 1,277.07 | 3,011.14 | 31,636.34 | 9.52 | 0.13 |
| 2022 | 19,316.72 | 669.24 | 1,577.97 | 33,094.10 | 4.76 | 0.20 |
| 2023 | 23,008.50 | 768.96 | 1,813.10 | 34,688.25 | 5.22 | 0.17 |
| 2024 | 25,169.21 | 2,081.23 | 4,907.24 | 39,394.25 | 12.46 | 0.12 |
| 2025 | 28,153.18 | 1,869.29 | 4,407.51 | 43,604.86 | 10.11 | 0.16 |
The annual revenue for the year-ending March 2025 increased to Rs 28,153.18 Crore from Rs 25,169.21 Crore in the year-ending March 2024. However, the net profit decreased to Rs 1,869.29 Crore from Rs 2,081.23 Crore.
| Income Statement Yearly (Rs Crore) | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | 28,153 | 25,169 | 23,008 | 19,316 | 16,163 |
| Other Income | 408 | 316 | 252 | 316 | 209 |
| Total Income | 28,561 | 25,486 | 23,261 | 19,633 | 16,373 |
| Total Expenditure | 25,722 | 22,345 | 21,872 | 18,471 | 14,361 |
| EBIT | 2,839 | 3,140 | 1,388 | 1,161 | 2,011 |
| Interest | 360 | 353 | 319 | 253 | 274 |
| Tax | 609 | 706 | 300 | 238 | 459 |
| Net Profit | 1,869 | 2,081 | 768 | 669 | 1,277 |
Balkrishna Ind's consolidated financial performance shows consistent revenue and net profit over the recent quarters. The company has also demonstrated steady growth in annual revenue.
| Quarter | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS |
|---|---|---|---|
| Jun 2024 | 2,714.50 | 489.99 | 25.35 |
| Sep 2024 | 2,419.74 | 346.94 | 17.95 |
| Dec 2024 | 2,560.33 | 449.48 | 23.25 |
| Mar 2025 | 2,752.38 | 368.55 | 19.06 |
| Jun 2025 | 2,760.02 | 288.30 | 14.91 |
The revenue for the quarter-ending June 2025 stood at Rs 2,760.02 Crore, compared to Rs 2,714.50 Crore for the quarter-ending June 2024. Net profit for the same period was Rs 288.30 Crore, down from Rs 489.99 Crore.
| Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2021 | 5,783.19 | 1,177.53 | 60.91 | 310.39 | 19.62 | 0.17 |
| 2022 | 8,295.12 | 1,435.38 | 74.25 | 358.67 | 20.70 | 0.36 |
| 2023 | 9,759.53 | 1,057.40 | 54.70 | 390.94 | 13.99 | 0.44 |
| 2024 | 9,368.87 | 1,471.49 | 76.12 | 458.04 | 16.61 | 0.35 |
| 2025 | 10,446.95 | 1,654.96 | 85.61 | 537.38 | 15.93 | 0.31 |
The annual revenue for the year-ending March 2025 increased to Rs 10,446.95 Crore from Rs 9,368.87 Crore in the year-ending March 2024. The net profit also increased to Rs 1,654.96 Crore from Rs 1,471.49 Crore.
| Income Statement Yearly (Rs Crore) | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | 10,446 | 9,368 | 9,759 | 8,295 | 5,783 |
| Other Income | 538 | 449 | 346 | 437 | 172 |
| Total Income | 10,985 | 9,818 | 10,106 | 8,733 | 5,955 |
| Total Expenditure | 8,670 | 7,764 | 8,623 | 6,741 | 4,389 |
| EBIT | 2,315 | 2,053 | 1,482 | 1,991 | 1,566 |
| Interest | 128 | 112 | 48 | 9 | 11 |
| Tax | 532 | 469 | 377 | 546 | 377 |
| Net Profit | 1,654 | 1,471 | 1,057 | 1,435 | 1,177 |
GE Vernova TD's financial data, though limited, indicates standalone performance with fluctuations in sales and net profit.
| Year | Revenue (Rs Crore) | Net Profit (Rs Crore) | EPS | BVPS | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| 2010 | 4,032.01 | 186.74 | 39.05 | 209.51 | 18.63 | 0.89 |
| Income Statement Yearly (Rs Crore) | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | 4,292 | 3,167 | 2,773 | 3,065 | 3,452 |
| Other Income | 62 | 22 | 33 | 25 | 65 |
| Total Income | 4,354 | 3,190 | 2,807 | 3,091 | 3,518 |
| Total Expenditure | 3,520 | 2,899 | 2,738 | 3,122 | 3,369 |
| EBIT | 833 | 291 | 68 | -30 | 148 |
| Interest | 14 | 28 | 42 | 38 | 59 |
| Tax | 211 | 82 | 28 | -19 | 29 |
| Net Profit | 608 | 181 | -1 | -49 | 60 |
KPR Mill
KPR Mill has scheduled analyst/investor meetings on September 5, 2025, September 8, 2025, and September 9, 2025, as announced under Regulation 30 (LODR).
The company announced a final dividend of Rs 2.50 per share on May 9, 2025, with an effective date of July 23, 2025. Additionally, an interim dividend of Rs 2.50 per share was announced on February 3, 2025, effective February 7, 2025. The company had a stock split on September 24, 2021.
Global Health
Global Health has scheduled analyst meetings, with the latest intimation on September 10, 2025. The company announced a final dividend of Rs 0.50 per share on May 15, 2025, with an effective date of August 22, 2025.
MRF
MRF has announced newspaper publications and re-lodgement of transfer requests for physical shares. The company announced a final dividend of Rs 229.00 per share on May 7, 2025, with an effective date of July 18, 2025. In addition, the company announced an interim dividend of Rs 3.00 per share on January 30, 2025, with an effective date of February 14, 2025.
Balkrishna Ind
Balkrishna Ind has scheduled analyst/investor meetings and announced newspaper publications. An interim dividend of Rs 4.00 per share was announced on July 18, 2025, with an effective date of July 31, 2025.
Analysis from Moneycontrol on September 12, 2025, indicated a bullish sentiment for the stock.
With KPR Mill at Rs 1,085.00, Global Health at Rs 1,371.80, MRF at Rs 152,035.00, Balkrishna Ind at Rs 2,468.00 and GE Vernova TD at Rs 2,920.10 the Nifty Midcap 150 witnessed significant activity.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
